Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02982694
Title Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vall d'Hebron Institute of Oncology
Indications

colorectal cancer

Therapies

Atezolizumab + Bevacizumab

Age Groups: adult | senior
Covered Countries ITA | ESP | BEL


No variant requirements are available.